TUESDAY, MARCH 28, 2017

First unmanned aerial vehicle to diagnose HIV in infants tested in Malawi

The Government of Malawi and UNICEF recently ran the initial test for the first Unmanned Aerial Vehicles (UAVs, commonly called drones) that may be used to decrease the waiting times to test infants for HIV infections. Read More »

No additional risk for surgical patients receiving influenza vaccine

A recent study suggests that there is no additional risk to surgical patients when they receive the seasonal influenza vaccine while they are still staying at the hospital. Read More »

Human challenge study to accelerate dengue vaccine development

Researchers recently conducted a controlled human challenge study that suggests an experimental dengue vaccine can give healthy volunteers full protection, urging experts to use this evidence to accelerate the development of a dengue vaccine. Read More »

U.K. Parliament holds first Evidence Session on meningitis B vaccine petition

The Meningitis Research Foundation (MRF) has commented on the inspiring, moving evidence that was presented at the first Evidence Session at the House of Commons about the upcoming parliamentary debate on a petition to require all people who live in the U,K, and who are under 11 years old, to receive the vaccine for meningitis B, or MenB. Read More »

Stanford chemists find ultra-sensitive test for HIV, cancer

A team of chemists from Stanford recently discovered a new, ultra-sensitive test that can detect cancer or HIV infections, suggesting that the test is significantly more sensitive than current technologies. Read More »

Scientists find simpler way to treat malaria

A team of chemists from the King Abdullah University of Science and Technology (KAUST) recently developed a new, simpler way to treat malaria with three powerful chemical groups in a single drug. Read More »

Dengue-fever test vaccine shows promise in early clinical trials

A team of scientists at the University of Vermont (UVM) Vaccine Testing Center has been working to develop an efficient, single-dose vaccine designed to protect people from the four strains of dengue fever, and the team said this week that clinical trials on a test vaccine have been promising so far. Read More »

New regimen reduces drug-resistant malaria severity during pregnancy

A recent study funded by the National Institutes of Health and conducted in Uganda found that a new treatment regimen involving two drugs may be able to reduce the severity of drug-resistant malaria during pregnancy. Read More »

New test may decrease TB death rates for HIV patients in sub-Saharan Africa

A team of scientists have developed a cost-efficient, simple, 25-minute urine test that diagnoses tuberculosis (TB) in HIV patients, which may be able to decrease the TB death rates among these patients in hospitals. Read More »

Preventive efforts reduce pediatric HIV infection in Nigeria study

A recent study of mother-to-child transmissions of human immunodeficiency virus (HIV) infections, the disease that causes AIDS, in Nigeria found that preventive health-care intervention measures helped reduce infections. Read More »

New biochip may provide fast, accurate HIV diagnosis

A new, differential immuno-capture biochip, created by researchers from the University of Illinois at Urbana-Champaign, is able to provide specific leukocyte counts that will help health professionals make a more accurate diagnosis of HIV infections. Read More »

NIAID's HOPE study looks at dapivirine vaginal rings to prevent HIV

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), will proceed with the HIV Open-label Prevention Extension (HOPE) Phase 3B trial to study the use of a dapivirine vaginal ring to prevent HIV in women.  Read More »

More than 2 million people have HIV and hepatitis C co-infections

A recent study from the University of Bristol and the London School of Hygiene & Tropical Medicine found that approximately 2.3 million people around the world have co-infections of human immunodeficiency virus (HIV) and hepatitis C (HCV). Read More »

Study reveals HIV targets tissue macrophages

A team of researchers in the Division of Infectious Diseases at the University of North Carolina School of Medicine recently found that human immunodeficiency virus (HIV) infections target tissue macrophages, which are large white blood cells located in the brain, liver and connective tissues. Read More »

WHO authorizes additional cholera vaccine supplies to stop worldwide shortage

The World Health Organization (WHO) recently approved an additional producer for the oral cholera vaccine, intending to resolve worldwide shortages of the vaccine by doubling the supply and extending service throughout more areas. Read More »

Rotary International invests $35 million in polio elimination

Rotary International recently invested $35 million in grants to various immunization activities and research projects that are designed to eliminate polio from the world health scene. Read More »

CDC adds eight countries to Zika virus travel guidelines

The Centers for Disease Control and Prevention (CDC) recently added new countries to its travel guidelines concerning the Zika virus, warning people who travel to these regions that the virus is at large. Read More »

Johns Hopkins researchers identify TB's natural resistance to antibiotics

Johns Hopkins University School of Medicine biophysicists recently found that the bacteria causing tuberculosis (TB) may be naturally resistant to antibiotics, called fluoroquinolones, which could help researchers strengthen TB drugs that have weakened over time. Read More »

Real-time system monitors Ebola through a microscope

Scientists recently published an article in mBio, a journal from the American Society for Microbiology, that suggests the first real-time system can monitor Ebola through a microscope while the Ebola-like virus particles infect and bond with human cells. Read More »

Hong Kong officials issue update on dengue fever

Officials with Hong Kong's Center for Health Protection (CHP) recently released a report with the latest figures for dengue fever cases. Read More »